0001564590-22-026785.txt : 20220728 0001564590-22-026785.hdr.sgml : 20220728 20220728070029 ACCESSION NUMBER: 0001564590-22-026785 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20220728 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220728 DATE AS OF CHANGE: 20220728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray Brands, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 824310622 FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 221112740 BUSINESS ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: Tilray, Inc. DATE OF NAME CHANGE: 20180213 8-K 1 tlry-8k_20220728.htm 8-K tlry-8k_20220728.htm
false 0001731348 0001731348 2022-07-28 2022-07-28

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 28, 2022

 

Tilray Brands, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-38594

82-4310622

(State or Other Jurisdiction

of Incorporation)

(Commission File

Number)

(IRS Employer

Identification No.)

 

 

 

265 Talbot Street West,
Leamington, ON

 

N8H 5L4

(Address of Principal Executive Offices,

 

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (844) 845-7291

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Class 2 Common Stock, $0.0001 par
value per share

 

TLRY

 

 

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 2.02

Results of Operations and Financial Condition.

On July 28, 2022, Tilray Brands, Inc. (“Tilray”) issued a press release announcing financial results for its fourth quarter and year ended May 31, 2022. A copy of the press release is furnished herewith as Exhibit 99.1.

The information in this current report on Form 8-K, including the press release attached as Exhibit 99.1 hereto, is being furnished, but shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Tilray, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

 

 

 

 

Exhibit
Number

  

Description

 

 

 

 

 

99.1

  

Press Release of Tilray Brands, Inc., dated July 28, 2022

 

 

 

104

  

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Tilray Brands, Inc.

 

 

 

 

Date:  July 28, 2022

 

By:

/s/ Mitchell Gendel

 

 

 

Global General Counsel

 

 

 

 

 

 

 EX-99.1 2 tlry-ex991_6.htm EX-99.1 tlry-ex991_6.htm

Exhibit 99.1

 

PRESS RELEASE

July 28, 2022

 

Tilray Brands, Inc. Reports                                                                                     Record Fiscal Year 2022 Results

 

FY2022 Net Revenue Grew 22% to $628 Million Compared to the Prior Year; On a Constant Currency Basis, Net Revenue Increased by 29%

 

Fourth Quarter Net Revenue Grew 8% to $153 Million Compared to the Prior Year Period; On a Constant Currency Basis, Net Revenue Increased by 14% to $163 Million

 

Company Expects to Generate $70-$80 Million of Adjusted EBITDA and be Free-Cash Flow Positive in Its Operating Business Units in FY2023

 

Foundation in Place for Profitable and Sustainable Growth

 

 

•

Fourth Quarter International Cannabis Increased 205% from the Prior Year Q4; Tilray Medical Leads European Medical Cannabis Market with 20% Market Share in Germany

 

 

•

Delivered $85 Million in Cost Savings to Date, Exceeding Original Target on Accelerated Timeline; Company Now Expects to Deliver $100 Million by the End of FY2023

 

 

•

Significantly Strengthened Balance Sheet, Reduced Debt, and Ended FY2022 with $416 Million in Cash

 

 

•

Tilray Brands Sets Stage for Next Evolution of Cannabis Following HEXO Transaction, which Positions the Company for Additional Growth Opportunities in Canada, Europe, and the U.S

 

NEW YORK and LEAMINGTON, ONTARIO – July 28, 2022 – Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today reported financial results for the fourth quarter and full fiscal year ended May 31, 2022.  All financial information in this press release is reported in U.S. dollars, unless otherwise indicated, and presented in accordance with accounting principles generally accepted in the U.S. (“GAAP”).  

Irwin D. Simon, Tilray Brands’ Chairman and Chief Executive Officer, stated, “Over the past year, we have accelerated the optimization of our operations and sharpened execution against our most profitable core business opportunities in medical, adult-use, wellness, and beverage-alcohol across Canada, Europe, and the U.S. At the same time, we accelerated our growth potential through tactical execution

 

 

 

PRESS RELEASE

July 28, 2022

 

and strategic initiatives that enable accelerated revenue growth through improved cultivation, brand building, and distribution. These actions should also contribute to bottom-line performance improvement through production efficiencies and cost reductions. The outcome of this work is that we have driven top line growth across our markets, significantly improved our operating performance, and strengthened our balance sheet.”

He continued, “We are confident that our proactive steps to plan for the evolution of the cannabis business in each of our markets has positioned Tilray Brands to be at the forefront of the industry on a global basis while delivering profitability and driving shareholder value.”

 

Financial Highlights - 2022 Fiscal Fourth Quarter1

•

Net revenue grew 8% to $153.3 million during the fourth quarter from $142.2 million in the prior year quarter. On a constant currency basis, net revenue increased 14.5%.

•

Net loss of $457.8 million during the fourth quarter compared to net income of $33.6 million in the prior year quarter. Net loss in the fiscal 2022 fourth quarter includes a non-cash impairment of $395.0 million primarily impacting inventory, goodwill and other intangible assets. The impact was related to changes in market opportunities causing a shift in our strategic priorities, and market conditions inclusive of higher rates of borrowing and lower foreign exchange rates.

•

Adjusted EBITDA of $11.5 million, marking the Company’s 13th consecutive quarter of positive Adjusted EBITDA.

 

Financial Highlights- 2022 Fiscal Year

•

Net revenue increased 22% to $628.4 million during fiscal 2022 from $513.1 million in the prior fiscal year. The increase was driven by 17.9% growth in cannabis net revenue to $237.5 million, a 150.0% increase in beverage alcohol net revenue of $71.5 million, and a 928.8% increase in wellness net revenue to $59.6 million.  On a constant currency basis, net revenue increased by 29%.

•

Net loss of $434 million in fiscal 2022 includes the non-cash impairment of $395.0 million in the fourth quarter (discussed above).

•

Adjusted EBITDA increased 17.8% to $48.0 million in fiscal year 2022 from $40.8 million in the prior fiscal year.

•

Ended the year with a strong balance sheet and liquidity, including cash and cash equivalents of $415.9 million.

 

Cost-Saving Synergies and Strengthened Balance Sheet

 

1 

This press release includes certain non-GAAP financial measures, which are intended to supplement, not substitute for, comparable GAAP financial measures. Reconciliations of non-GAAP financial measures to GAAP financial measures and other non-GAAP financial calculations are provided herein in the tables.

Tilray Brands, Inc. | www.tilray.com

 

 

PRESS RELEASE

July 28, 2022

 

 

Since the closing of the Tilray-Aphria transaction, the Company has delivered $85 million in cost synergies, exceeding its original target of delivering $80 million of cost savings by the end of fiscal year 2023.  These synergies are due to consolidation in key areas of cultivation and production, cannabis and product purchasing, sales and marketing, and corporate expenses. The Company has subsequently identified an additional $20 million of savings, and now expects to deliver a total of $100 million in cost synergies from the transaction by the end of fiscal year 2023.

Further, with the benefit of an additional $80 million of shared cost savings, synergies and financial benefits over the next two years associated with the HEXO transaction, management expects that Tilray Brands will be free cash flow positive in its business units in fiscal year 2023.

 

Upside Potential of HEXO Transaction

Tilray Brands’ acquisition of HEXO Corp.’s senior secured convertible note, on highly favorable terms, closed on July 12, 2022, bringing immediate accretion to the Company and facilitating collaboration and the sharing of best practices that will help Tilray Brands to drive ongoing international expansion and take advantage of the opportunities expected to come with federal legalization in the U.S. In addition, due to significant operating efficiencies, the companies expect to deliver a total of $80 million of shared cost savings over the next two years.

 

Highlights of Strategic Growth Actions in Fiscal 2022

United States:

•

August ’21 - Tilray Acquires Majority Position in Amended MedMen Convertible Notes 

•

November ’21 - Tilray’s SweetWater Brand Enters Spirits Category Through New Ready-To-Drink Cocktail Now Available in the United States 

•

December ’21 - Tilray Strengthens Strategic Position in the U.S. with Acquisition of Breckenridge Distillery 

•

December ’21 - SweetWater Brewing announced the acquisition of Alpine Beer Company and Green Flash Brewing Company

•

January ’22 – Manitoba Harvest Launches 2022 Wellness Boost Campaign

•

February ’22 - SweetWater Brewing Company Expands Distribution Across California 

•

February ’22 - SweetWater Brewing Company Continues Rapid Expansion with Distribution Rollout Across Washington & Oregon 

•

April ’22 - SweetWater Brewing Company celebrated 25th anniversary and hosted 420 music Festival in Atlanta, Georgia with 75 thousand festival goers

•

April ’22 - Manitoba Harvest Enters Exclusive Partnership with Whole Foods Market

•

April ’22 - Breckenridge Distillery Takes Home Two Double Gold and One Gold Medal at the 2022 San Francisco World Spirits Competition

•

April ’22 – Breckenridge Distillery Launches New Collectors Art Series with Denver Artist Alexandrea Pangburn

Tilray Brands, Inc. | www.tilray.com

 

 

PRESS RELEASE

July 28, 2022

 

 

Canada:

•

June ’21 - Tilray Launches New Medical Cannabis Brand, Symbios 

•

June ’21 - Tilray Launches Canadian Craft Cannabis Brand, Broken Coast, in the U.S. with Broken Coast Lager 

•

August ’21 – Tilray Medical Launches New Medical Cannabis Edibles in Canada 

•

October ’21 - Tilray Strengthens Leadership Position in Canada with new addition of Blair MacNeil, President of Canada 

•

October ’21 - Tilray Expands Distribution across Canada with Great North Distributors 

•

December ’21 - Launch of Tilray’s Fast-Acting Oral Strips Highlights Commitment to Medical Cannabis Innovation and Patient Care 

•

March ’22 - Good Supply Brand Expands Its Award-Winning Cannabis Portfolio with Hash Bats™; A New ‘Hard-Hitting’ Infused Pre-Roll 

•

March ’22 - Solei Brand Launches New Wellness Product for Nighttime Use 

•

April ’22 - Solei Brand Launches the First Cannabis Edible Available in Quebec 

•

April ’22 - Tilray Brands hosts sold-out ‘Holy Smokes’ 420 Budtender event in Toronto

•

May ’22 - Good Supply Brand Expands High-Potency Cannabis Portfolio with Launch of Liquid Wax Vapes and New Exclusive Strains 

 

Europe and International:

•

July ’21 – Tilray’s Aphria RX GmbH Completes First Harvest and Delivery of Medical Cannabis Grown in Germany 

•

October ’21 – Tilray Launches Medical Cannabis in Luxembourg

•

November ’21 - Tilray Expands Medical Cannabis Footprint in Malta 

•

January ’22 - Tilray Expands Medical Cannabis Product Offering in Australia 

•

February ‘22 - Tilray Brands Consolidates its Global Medical Offering into Tilray Medical, a Comprehensive Portfolio of Brands and Products 

•

February ’22 - Tilray Launches Medical Cannabis Products in Malta 

•

March ’22 - Tilray Medical Expands Offering in Malta and Launches First Medical Cannabis Oil Products in Market 

•

May ’22 - Announced the launch of CBD lifestyle brand, POLLEN, on Amazon UK 

 

Webcast

Tilray Brands will host a webcast to discuss these results today at 8:30 a.m. ET. Investors may join the live webcast available on the Investors section of the Company’s website at www.tilray.com. The webcast will also be archived after the call concludes.

About Tilray Brands

Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin

Tilray Brands, Inc. | www.tilray.com

 

 

PRESS RELEASE

July 28, 2022

 

America that is changing people's lives for the better – one person at a time. Tilray Brands delivers on this mission by inspiring and empowering the worldwide community to live their very best life, enhanced by moments of connection and wellbeing. Patients and consumers trust Tilray Brands to be the most responsible, trusted and market leading cannabis consumer products company in the world with a portfolio of innovative, high-quality and beloved brands that address the needs of the consumers, customers and patients we serve. A pioneer in cannabis research, cultivation, and distribution, Tilray Brands’ unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on Tilray Brands, visit www.Tilray.com and follow @Tilray

Cautionary Statement Concerning Forward-Looking Statements

Certain statements in this press release constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words.   Certain material factors, estimates, goals, projections or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication.

Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things: the Company’s ability to become the world's leading cannabis-focused consumer branded company and achieve $4B in revenue by the end of fiscal 2024; the Company’s ability to generate $70-$80 million of Adjusted EBITDA and expectation to be free-cash flow positive in its operating business units in FY 2023; the Company’s ability to achieve operational scale, market share, distribution, profitability and revenue growth in particular markets, including in Canada, the U.S. and the EU; and the Company’s ability to successfully achieve the expected production efficiencies, synergies and cost savings relating to the HEXO transactions and agreed commercial arrangements; and the Company’s anticipated investments, including in organic and strategic growth, partnership efforts, product offerings and other initiatives.

Many factors could cause actual results, performance or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of the Company and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of the Company made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws.

 

Use of Non-U.S. GAAP Financial Measures

This press release and the accompanying tables include non-GAAP financial measures, including adjusted gross margin, Adjusted EBITDA and free cash flow. Management believes that the non-GAAP financial measures presented provide useful additional information to investors about current trends in the Company's operations and are useful for period-over-period comparisons of operations. These non-GAAP financial measures should not be

Tilray Brands, Inc. | www.tilray.com

 

 

PRESS RELEASE

July 28, 2022

 

considered in isolation or as a substitute for the comparable GAAP measures. In addition, these non-GAAP measures may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded. They should be read only in connection with the Company's Consolidated Statements of Operations and Cash Flows presented in accordance with GAAP.

Certain forward-looking non-GAAP financial measures included in this press release are not reconciled to the comparable forward-looking GAAP financial measures. The Company is not able to reconcile these forward-looking non-GAAP financial measures to their most directly comparable forward-looking GAAP financial measures without unreasonable efforts because the Company is unable to predict with a reasonable degree of certainty the type and extent of certain items that would be expected to impact GAAP measures but would not impact the non-GAAP measures. Such items may include litigation and related expenses, transaction costs, impairments, foreign exchange movements and other items. The unavailable information could have a significant impact on the Company's GAAP financial results.

The Company believes presenting net sales at constant currency provides useful information to investors because it provides transparency to underlying performance in the Company's consolidated net sales by excluding the effect that foreign currency exchange rate fluctuations have on period-to-period comparability given the volatility in foreign currency exchange markets. To present this information for historical periods, current period net sales for entities reporting in currencies other than the U.S. dollar are translated into U.S. dollars at the average monthly exchange rates in effect during the corresponding period of the prior fiscal year, rather than at the actual average monthly exchange rate in effect during the current period of the current fiscal year. As a result, the foreign currency impact is equal to the current year results in local currencies multiplied by the change in average foreign currency exchange rate between the current fiscal period and the corresponding period of the prior fiscal year.

Adjusted EBITDA is calculated as net income (loss) before inventory valuation adjustments; interest expenses, net; other expenses (income), net; deferred income tax (recoveries) expenses, current income tax expenses (benefit); foreign exchange gain (loss), net; depreciation and amortization expenses; stock-based compensation expenses; loss from equity method investments; loss on disposal of property and equipment; amortization of inventory step-up; severance costs; impairment of assets; and change in fair value of warrant liability. A reconciliation of Adjusted EBITDA to net loss, the most directly comparable GAAP measure, has been provided in the financial statement tables included below in this press release. Gross margin, excluding inventory valuation adjustments, is calculated as revenue less cost of sales adjusted to add back inventory valuation adjustments and amortization of inventory step-up, divided by revenue. A reconciliation of Gross margin, excluding inventory valuation adjustments, to gross margin, the most directly comparable GAAP measure, has been provided in the financial statement tables included below in this press release.  Free cash flow is comprised of two GAAP measures deducted from each other which are net cash flow provided by (used in) operating activities less investments in capital and intangible assets. A reconciliation of net cash flow provided by (used in) operating activities to free cash flow, the most directly comparable GAAP measure, has been provided in the financial statement tables included below in this press release.

 

For further information:

Media: Berrin Noorata, news@tilray.com

Investors: Raphael Gross, +1-203-682-8253, Raphael.Gross@icrinc.com

 

Tilray Brands, Inc. | www.tilray.com

 

 

PRESS RELEASE

July 28, 2022

 

 

Consolidated Statements of Financial Position

 

(In thousands of United States dollars)

 

May 31,

2022

 

 

May 31,

2021

 

Assets

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

415,909

 

 

$

488,466

 

Accounts receivable, net

 

 

95,279

 

 

 

87,309

 

Inventory

 

 

245,529

 

 

 

256,429

 

Prepaids and other current assets

 

 

46,786

 

 

 

48,920

 

Current portion of convertible notes receivable

 

 

—

 

 

 

2,485

 

Total current assets

 

 

803,503

 

 

 

883,609

 

Capital assets

 

 

587,499

 

 

 

650,698

 

Right-of-use assets

 

 

12,996

 

 

 

18,267

 

Intangible assets

 

 

1,277,875

 

 

 

1,605,918

 

Goodwill

 

 

2,641,305

 

 

 

2,832,794

 

Interest in equity investees

 

 

4,952

 

 

 

8,106

 

Long-term investments

 

 

10,050

 

 

 

17,685

 

Convertible notes receivable

 

 

111,200

 

 

 

—

 

Other assets

 

 

314

 

 

 

8,285

 

Total assets

 

$

5,449,694

 

 

$

6,025,362

 

Liabilities

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Bank indebtedness

 

$

18,123

 

 

$

8,717

 

Accounts payable and accrued liabilities

 

 

157,431

 

 

 

212,813

 

Contingent consideration

 

 

16,007

 

 

 

60,657

 

Warrant liability

 

 

14,255

 

 

 

78,168

 

Current portion of lease liabilities

 

 

6,703

 

 

 

4,264

 

Current portion of long-term debt

 

 

67,823

 

 

 

36,622

 

Total current liabilities

 

 

280,342

 

 

 

401,241

 

Lease liabilities

 

 

11,329

 

 

 

53,946

 

Long-term debt

 

 

117,879

 

 

 

167,486

 

Convertible debentures

 

 

401,949

 

 

 

667,624

 

Deferred tax liabilities, net

 

 

196,638

 

 

 

265,845

 

Other liabilities

 

 

191

 

 

 

3,907

 

Total liabilities

 

 

1,008,328

 

 

 

1,560,049

 

Commitments and contingencies (refer to Note 17)

 

 

 

 

 

 

 

 

Stockholders' equity

 

 

 

 

 

 

 

 

Common stock ($0.0001 par value; 990,000,000 shares authorized; 532,674,887 and 446,440,641 shares issued and outstanding, respectively)

 

 

53

 

 

 

46

 

Additional paid-in capital

 

 

5,382,367

 

 

 

4,792,406

 

Accumulated other comprehensive (deficit) income (loss)

 

 

(20,764

)

 

 

152,668

 

Accumulated deficit

 

 

(962,851

)

 

 

(486,050

)

Total Tilray Brands, Inc. stockholders' equity

 

 

4,398,805

 

 

 

4,459,070

 

Non-controlling interests

 

 

42,561

 

 

 

6,243

 

Total stockholders' equity

 

 

4,441,366

 

 

 

4,465,313

 

Total liabilities and stockholders' equity

 

$

5,449,694

 

 

$

6,025,362

 

Tilray Brands, Inc. | www.tilray.com

 

 

PRESS RELEASE

July 28, 2022

 

 

Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)

(In thousands of United States dollars,

 

For the three months ended May 31,

For the year ended May 31,

except for per share data)

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

Net revenue

 

$

153,325

 

 

$

142,236

 

 

$

628,372

 

 

$

513,085

 

 

Cost of goods sold

 

 

160,058

 

 

 

119,738

 

 

 

511,555

 

 

 

389,903

 

 

Gross profit

 

 

(6,733

)

 

 

22,498

 

 

 

116,817

 

 

 

123,182

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

 

41,400

 

 

 

32,839

 

 

 

162,801

 

 

 

111,575

 

 

Selling

 

 

9,643

 

 

 

8,525

 

 

 

34,926

 

 

 

26,576

 

 

Amortization

 

 

30,846

 

 

 

16,100

 

 

 

115,191

 

 

 

35,221

 

 

Marketing and promotion

 

 

10,771

 

 

 

5,103

 

 

 

30,934

 

 

 

17,539

 

 

Research and development

 

 

54

 

 

 

358

 

 

 

1,518

 

 

 

830

 

 

Change in fair value of contingent consideration

 

 

(15,585

)

 

 

—

 

 

 

(44,650

)

 

 

—

 

 

Impairment

 

 

378,241

 

 

 

—

 

 

 

378,241

 

 

 

—

 

 

Litigation costs

 

 

4,099

 

 

 

2,099

 

 

 

16,518

 

 

 

3,251

 

 

Transaction costs

 

 

1,221

 

 

 

31,161

 

 

 

31,739

 

 

 

60,361

 

 

Total operating expenses

 

 

460,690

 

 

 

96,185

 

 

 

727,218

 

 

 

255,353

 

 

Operating loss

 

 

(467,423

)

 

 

(73,687

)

 

 

(610,401

)

 

 

(132,171

)

 

Interest expense, net

 

 

(5,522

)

 

 

(9,466

)

 

 

(27,944

)

 

 

(27,977

)

 

Non-operating income (expense), net

 

 

11,342

 

 

 

121,510

 

 

 

197,671

 

 

 

(184,838

)

 

Loss before income taxes

 

 

(461,603

)

 

 

38,357

 

 

 

(440,674

)

 

 

(344,986

)

 

Income taxes (recovery)

 

 

(3,803

)

 

 

4,735

 

 

 

(6,542

)

 

 

(8,972

)

 

Net loss

 

$

(457,800

)

 

$

33,622

 

 

$

(434,132

)

 

$

(336,014

)

 

Net loss per share - basic and diluted

 

$

(0.90

)

 

$

0.38

 

 

$

(0.90

)

 

$

(1.25

)

 

 

Net Revenue by Operating Segment

 

(In thousands of United States dollars)

 

Three months ended

May 31, 2022

 

 

% of Total Revenue

 

 

Three months ended

May 31, 2021

 

 

% of Total Revenue

 

 

Cannabis business

 

$

53,253

 

 

35%

 

 

$

53,703

 

 

38%

 

 

Distribution business

 

 

61,160

 

 

39%

 

 

 

66,792

 

 

47%

 

 

Beverage alcohol business

 

 

22,727

 

 

15%

 

 

 

15,947

 

 

11%

 

 

Wellness business

 

 

16,185

 

 

11%

 

 

 

5,794

 

 

4%

 

 

Net revenue

 

$

153,325

 

 

100%

 

 

$

142,236

 

 

100%

 

 

 

(In thousands of United States dollars)

 

Year Ended

May 31, 2022

 

 

% of Total Revenue

 

 

Year Ended

May 31, 2022

 

 

% of Total Revenue

 

 

Cannabis business

 

$

237,522

 

 

38%

 

 

$

201,392

 

 

39%

 

 

Distribution business

 

 

259,747

 

 

42%

 

 

 

277,300

 

 

54%

 

 

Beverage alcohol business

 

 

71,492

 

 

11%

 

 

 

28,599

 

 

6%

 

 

Wellness business

 

 

59,611

 

 

9%

 

 

 

5,794

 

 

1%

 

 

Net revenue

 

$

628,372

 

 

100%

 

 

$

513,085

 

 

100%

 

 

 

 

 

 

 

Net Cannabis Revenue by Market Channel

Tilray Brands, Inc. | www.tilray.com

 

 

PRESS RELEASE

July 28, 2022

 

 

 

 

For the three months ended May 31,

 

 

For the three months ended May 31,

(In thousands of United States dollars)

 

2022

 

 

2022

 

 

2021

 

 

2021

 

Revenue from Canadian medical cannabis products

 

$

7,246

 

 

14%

 

 

$

6,968

 

 

13%

 

Revenue from Canadian adult-use cannabis products

 

 

46,869

 

 

88%

 

 

 

59,710

 

 

111%

 

Revenue from wholesale cannabis products

 

 

141

 

 

0%

 

 

 

56

 

 

0%

 

Revenue from international cannabis products

 

 

14,095

 

 

26%

 

 

 

4,623

 

 

9%

 

Less excise taxes

 

 

(15,098

)

 

-28%

 

 

 

(17,654

)

 

-33%

 

Total

 

$

53,253

 

 

100%

 

 

$

53,703

 

 

100%

 

 

(In thousands of United States dollars)

 

For the year ended May 31,

 

 

For the year ended May 31,

 

 

 

2022

 

 

2022

 

 

2021

 

 

2021

 

Revenue from Canadian medical cannabis products

 

$

30,599

 

 

13%

 

 

$

25,539

 

 

13%

 

Revenue from Canadian adult-use cannabis products

 

 

209,501

 

 

88%

 

 

 

222,930

 

 

110%

 

Revenue from wholesale cannabis products

 

 

6,904

 

 

3%

 

 

 

6,615

 

 

3%

 

Revenue from international cannabis products

 

 

53,887

 

 

23%

 

 

 

9,250

 

 

5%

 

Less excise taxes

 

 

(63,369

)

 

-27%

 

 

 

(62,942

)

 

-31%

 

Total

 

$

237,522

 

 

100%

 

 

$

201,392

 

 

100%

 

 

Other Financial Information: Key Operating Metrics

 

 

For the three months ended May 31,

 

 

For the years ended May 31,

 

(In thousands of United States dollars)

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Net cannabis revenue

 

$

53,253

 

 

$

53,703

 

 

$

237,522

 

 

$

201,392

 

Net beverage alcohol revenue

 

 

22,727

 

 

 

15,947

 

 

 

71,492

 

 

 

28,599

 

Distribution revenue

 

 

61,160

 

 

 

66,792

 

 

 

259,747

 

 

 

277,300

 

Wellness revenue

 

 

16,185

 

 

 

5,794

 

 

 

59,611

 

 

 

5,794

 

Cannabis cost of sales

 

 

72,342

 

 

 

49,731

 

 

 

194,834

 

 

 

130,511

 

Beverage alcohol cost of sales

 

 

11,359

 

 

 

5,350

 

 

 

32,033

 

 

 

12,687

 

Distribution cost of sales

 

 

65,138

 

 

 

60,424

 

 

 

243,231

 

 

 

242,472

 

Wellness cost of sales

 

 

11,219

 

 

 

4,233

 

 

 

41,457

 

 

 

4,233

 

Gross profit (excluding inventory valuation adjustments and step-up)

 

 

50,481

 

 

 

43,252

 

 

 

186,031

 

 

 

143,936

 

Cannabis gross margin (excluding inventory valuation adjustments and step-up)

 

 

53.4

%

 

 

44.5

%

 

 

43.0

%

 

 

45.1

%

Beverage gross margin (excluding inventory valuation adjustments and step-up)

 

 

59.8

%

 

 

71.7

%

 

 

58.3

%

 

 

58.6

%

Distribution gross margin (excluding inventory valuation adjustments and step-up)

 

 

5.8

%

 

 

9.5

%

 

 

9.2

%

 

 

12.6

%

Wellness gross margin (excluding inventory valuation adjustments and step-up)

 

 

30.7

%

 

 

26.9

%

 

 

30.5

%

 

 

26.9

%

Adjusted EBITDA

 

 

11,504

 

 

 

13,195

 

 

 

48,047

 

 

 

40,771

 

Cash and cash equivalents

 

 

415,909

 

 

 

488,466

 

 

 

415,909

 

 

 

488,466

 

Working capital

 

 

523,161

 

 

 

479,883

 

 

 

523,161

 

 

 

482,368

 

 

 

 

 

Other Financial Information: Gross Margin and Adjusted Gross Margin

Tilray Brands, Inc. | www.tilray.com

 

 

PRESS RELEASE

July 28, 2022

 

 

(In thousands of United States dollars)

 

For the three months ended May 31, 2022

 

 

 

Cannabis

 

 

Beverage

 

 

Distribution

 

 

Wellness

 

 

Total

 

Revenue

 

$

68,351

 

 

$

23,459

 

 

$

61,160

 

 

$

16,185

 

 

$

169,155

 

Excise taxes

 

 

(15,098

)

 

 

(732

)

 

 

—

 

 

 

—

 

 

 

(15,830

)

Net revenue

 

 

53,253

 

 

 

22,727

 

 

 

61,160

 

 

 

16,185

 

 

 

153,325

 

Cost of goods sold

 

 

72,342

 

 

 

11,359

 

 

 

65,138

 

 

 

11,219

 

 

 

160,058

 

Gross profit

 

 

(19,089

)

 

 

11,368

 

 

 

(3,978

)

 

 

4,966

 

 

 

(6,733

)

Gross margin

 

 

-35.8

%

 

 

50.0

%

 

 

-6.5

%

 

 

30.7

%

 

 

-4.4

%

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Inventory valuation adjustments

 

 

47,500

 

 

 

—

 

 

 

7,500

 

 

 

—

 

 

 

55,000

 

Purchase price accounting step-up

 

 

—

 

 

 

2,214

 

 

 

—

 

 

 

—

 

 

 

2,214

 

Adjusted gross profit

 

 

28,411

 

 

 

13,582

 

 

 

3,522

 

 

 

4,966

 

 

 

50,481

 

Adjusted gross margin

 

 

53.4

%

 

 

59.8

%

 

 

5.8

%

 

 

30.7

%

 

 

32.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(In thousands of United States dollars)

 

For the three months ended May 31, 2021

 

 

 

Cannabis

 

 

Beverage

 

 

Distribution

 

 

Wellness

 

 

Total

 

Revenue

 

$

71,357

 

 

$

16,549

 

 

$

66,792

 

 

$

5,794

 

 

$

160,492

 

Excise taxes

 

 

(17,654

)

 

 

(602

)

 

 

—

 

 

 

—

 

 

 

(18,256

)

Net revenue

 

 

53,703

 

 

 

15,947

 

 

 

66,792

 

 

 

5,794

 

 

 

142,236

 

Cost of goods sold

 

 

49,731

 

 

 

5,350

 

 

 

60,424

 

 

 

4,233

 

 

 

119,738

 

Gross profit

 

 

3,972

 

 

 

10,597

 

 

 

6,368

 

 

 

1,561

 

 

 

22,498

 

Gross margin

 

 

7.4

%

 

 

66.5

%

 

 

9.5

%

 

 

26.9

%

 

 

15.8

%

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Inventory valuation adjustments

 

 

19,919

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

19,919

 

Purchase price accounting step-up

 

 

—

 

 

 

835

 

 

 

—

 

 

 

—

 

 

 

835

 

Adjusted gross profit

 

 

23,891

 

 

 

11,432

 

 

 

6,368

 

 

 

1,561

 

 

 

43,252

 

Adjusted gross margin

 

 

44.5

%

 

 

71.7

%

 

 

9.5

%

 

 

26.9

%

 

 

30.4

%

 

(In thousands of United States dollars)

 

For the year ended May 31, 2022

 

 

 

Cannabis

 

 

Beverage

 

 

Distribution

 

 

Wellness

 

 

Total

 

Revenue

 

$

300,891

 

 

$

74,959

 

 

$

259,747

 

 

$

59,611

 

 

$

695,208

 

Excise taxes

 

 

(63,369

)

 

 

(3,467

)

 

 

—

 

 

 

—

 

 

 

(66,836

)

Net revenue

 

 

237,522

 

 

 

71,492

 

 

 

259,747

 

 

 

59,611

 

 

 

628,372

 

Cost of goods sold

 

 

194,834

 

 

 

32,033

 

 

 

243,231

 

 

 

41,457

 

 

 

511,555

 

Gross profit

 

 

42,688

 

 

 

39,459

 

 

 

16,516

 

 

 

18,154

 

 

 

116,817

 

Gross margin

 

 

18.0

%

 

 

55.2

%

 

 

6.4

%

 

 

30.5

%

 

 

18.6

%

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Inventory valuation adjustments

 

 

59,500

 

 

 

—

 

 

 

7,500

 

 

 

—

 

 

 

67,000

 

Purchase price accounting step-up

 

 

—

 

 

 

2,214

 

 

 

—

 

 

 

—

 

 

 

2,214

 

Adjusted gross profit

 

 

102,188

 

 

 

41,673

 

 

 

24,016

 

 

 

18,154

 

 

 

186,031

 

Adjusted gross margin

 

 

43.0

%

 

 

58.3

%

 

 

9.2

%

 

 

30.5

%

 

 

29.6

%

 

 

 

 

Tilray Brands, Inc. | www.tilray.com

 

 

PRESS RELEASE

July 28, 2022

 

 

(In thousands of United States dollars)

 

For the year ended May 31, 2021

 

 

 

Cannabis

 

 

Beverage

 

 

Distribution

 

 

Wellness

 

 

Total

 

Revenue

 

$

264,334

 

 

$

29,661

 

 

$

277,300

 

 

$

5,794

 

 

$

577,089

 

Excise taxes

 

 

(62,942

)

 

 

(1,062

)

 

 

—

 

 

 

—

 

 

 

(64,004

)

Net revenue

 

 

201,392

 

 

 

28,599

 

 

 

277,300

 

 

 

5,794

 

 

 

513,085

 

Cost of goods sold

 

 

130,511

 

 

 

12,687

 

 

 

242,472

 

 

 

4,233

 

 

 

389,903

 

Gross profit

 

 

70,881

 

 

 

15,912

 

 

 

34,828

 

 

 

1,561

 

 

 

123,182

 

Gross margin

 

 

35.2

%

 

 

55.6

%

 

 

12.6

%

 

 

26.9

%

 

 

24.0

%

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Inventory valuation adjustments

 

 

19,919

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

19,919

 

Purchase price accounting step-up

 

 

—

 

 

 

835

 

 

 

—

 

 

 

—

 

 

 

835

 

Adjusted gross profit

 

 

90,800

 

 

 

16,747

 

 

 

34,828

 

 

 

1,561

 

 

 

143,936

 

Adjusted gross margin

 

 

45.1

%

 

 

58.6

%

 

 

12.6

%

 

 

26.9

%

 

 

28.1

%

 

Other Financial Information: Adjusted Earnings before Interest, Taxes, and Amortization

 

 

Three months ended May 31,

 

 

Year ended May 31,

 

 

Adjusted EBITDA reconciliation:

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

Net loss

 

$

(457,800

)

 

$

33,622

 

 

$

(434,132

)

 

$

(336,014

)

 

Income taxes

 

 

(3,803

)

 

 

4,735

 

 

 

(6,542

)

 

 

(8,972

)

 

Interest expense, net

 

 

5,522

 

 

 

9,466

 

 

 

27,944

 

 

 

27,977

 

 

Non-operating expense (income), net

 

 

(11,350

)

 

 

(121,510

)

 

 

(197,671

)

 

 

184,838

 

 

Amortization

 

 

40,768

 

 

 

24,540

 

 

 

154,592

 

 

 

67,832

 

 

Stock-based compensation

 

 

8,969

 

 

 

5,937

 

 

 

35,994

 

 

 

17,351

 

 

Change in fair value of contingent consideration

 

 

(15,577

)

 

 

—

 

 

 

(44,650

)

 

 

—

 

 

Impairment

 

 

378,241

 

 

 

—

 

 

 

378,241

 

 

 

—

 

 

Inventory valuation adjustments

 

 

55,000

 

 

 

19,919

 

 

 

67,000

 

 

 

19,919

 

 

Purchase price accounting step up

 

 

2,214

 

 

 

835

 

 

 

2,214

 

 

 

835

 

 

Facility start-up and closure costs

 

 

3,300

 

 

 

2,056

 

 

 

13,700

 

 

 

2,056

 

 

Lease expense

 

 

700

 

 

 

335

 

 

 

3,100

 

 

 

1,337

 

 

Litigation costs

 

 

4,099

 

 

 

2,099

 

 

 

16,518

 

 

 

3,251

 

 

Transaction costs

 

 

1,221

 

 

 

31,161

 

 

 

31,739

 

 

 

60,361

 

 

Adjusted EBITDA

 

$

11,504

 

 

$

13,195

 

 

$

48,047

 

 

$

40,771

 

 

 

Tilray Brands, Inc. | www.tilray.com

 GRAPHIC 3 gexthshexaly000003.jpg GRAPHIC begin 644 gexthshexaly000003.jpg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end GRAPHIC 4 gexthshexaly000001.jpg GRAPHIC begin 644 gexthshexaly000001.jpg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tlry-20220728.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 6 tlry-20220728_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre Commencement Tender Offer Pre-commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Entity Central Index Key Title of 12(b) Security Security12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name EX-101.PRE 7 tlry-20220728_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Document and Entity Information
Jul. 28, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 28, 2022
Entity Registrant Name Tilray Brands, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-38594
Entity Tax Identification Number 82-4310622
Entity Address, Address Line One 265 Talbot Street West
Entity Address, City or Town Leamington
Entity Address, State or Province ON
Entity Address, Postal Zip Code N8H 5L4
City Area Code 844
Local Phone Number 845-7291
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001731348
Title of 12(b) Security Class 2 Common Stock, $0.0001 parvalue per share
Trading Symbol TLRY
Security Exchange Name NASDAQ
XML 9 tlry-8k_20220728_htm.xml IDEA: XBRL DOCUMENT 0001731348 2022-07-28 2022-07-28 false 0001731348 8-K 2022-07-28 Tilray Brands, Inc. DE 001-38594 82-4310622 265 Talbot Street West Leamington ON N8H 5L4 844 845-7291 false false false false Class 2 Common Stock, $0.0001 parvalue per share TLRY NASDAQ false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports tlry-8k_20220728.htm tlry-20220728.xsd tlry-20220728_lab.xml tlry-20220728_pre.xml tlry-ex991_6.htm http://xbrl.sec.gov/dei/2022 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tlry-8k_20220728.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "tlry-8k_20220728.htm" ] }, "labelLink": { "local": [ "tlry-20220728_lab.xml" ] }, "presentationLink": { "local": [ "tlry-20220728_pre.xml" ] }, "schema": { "local": [ "tlry-20220728.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "tlry", "nsuri": "http://www.tilray.com/20220728", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "tlry-8k_20220728.htm", "contextRef": "C_0001731348_20220728_20220728", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "tlry-8k_20220728.htm", "contextRef": "C_0001731348_20220728_20220728", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "verboseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tilray.com/20220728/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0001564590-22-026785-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-22-026785-xbrl.zip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end